Sears Holdings Corp. (NASDAQ: SHLD) released its first-quarter numbers and the results looked like a reason to celebrate as profits jumped up by 20%. Where did that 20% come from? How about insurance money from Sears locations damaged by 2005 hurricanes and an unrelated legal settlement? In other words, the boring business of retail in Kmart and Sears stores really did not contribute to success here. Surprised?
Net income for the quarter rose to $216 million from $180 million while sales fell 2.5% to $11.7 billion. Yawn. In addition, same-store sales for the quarter fell 3.9% on less demand for home appliances at Sears and slower sales of health and beauty products at Kmart. Since I'm sure many Americans buy health and beauty products at Kmart, I think I'm buying the home appliance sales slowdown in Sears stores more as a reason here. But could that alone have contributed to a 3.9% same-store sales decline?
With Sears Holdings being more of an investment house and clearinghouse for Eddie Lampert rather than a thriving retailer bent on increasing market share, these results aren't surprising. From my experience, Sears stores are mostly dirty locations with what seems like a 1980s-era merchandising mindset (not sure about Kmart -- someone want to chime in here?).
Same-store sales have fallen every quarter since Sears and Kmart combined in 2005 and they don't look to get any better soon. Let's see if Lampert is serious about actually spending money to improve the retailer's operations here. So far, zilch -- and it shows.
Last updated: February 13, 2012: 07:02 AM
Hot Stocks
DailyFinance Headlines
- How State Taxes Put a Bigger Pinch on the Poor
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
Benzinga Headlines
- Michigan Consumer Sentiment Index Drops
- Don't Bank on Barclays
- GSV Capital Punished for Expanding Facebook Investment
- Chesapeake Gently Lets Go of Gas
- How to Profit off Addicts
TheFlyOnTheWall.com Headlines
- Dover to acquire Maag Group
- Lattice Semi ships more than 20M programmable mixed signal products
- On the Fly: Periodicals Wrap-Up
- Yahoo!'s product unit to undergo major reorganization, All Things Digital says
- SKF Group to acquire General Bearing Corp.
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- How State Taxes Put a Bigger Pinch on the Poor
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
Walmart's New Health Food Push: Is It Too Hard to Swallow?
Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger

